Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 121 articles:
HTML format
Text format



Single Articles


    June 2017
  1. CHUNG JR, Flannery B, Zimmerman RK, Nowalk MP, et al
    Prior season vaccination and risk of influenza during the 2014-2015 season in the U.S.
    J Infect Dis. 2017 Jun 13. doi: 10.1093.
    PubMed     Text format    


  2. HUANG LM, Puthanakit T, Cheng-Hsun C, Ren-Bin T, et al
    Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial.
    J Infect Dis. 2017 Jun 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. QENDRI V, Bogaards JA, Berkhof J
    Health and economic impact of a tender-based gender-neutral HPV16/18 vaccination program in the Netherlands.
    J Infect Dis. 2017 Jun 6. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  4. HALPERIN SA, Arribas JR, Rupp R, Andrews CP, et al
    Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults.
    J Infect Dis. 2017 May 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  5. FLECKENSTEIN JM
    Providing Structure to Enterotoxigenic Escherichia coli Vaccine Development.
    J Infect Dis. 2017 May 24. doi: 10.1093.
    PubMed     Text format    


  6. LOCHT C, Papin JF, Lecher S, Debrie AS, et al
    Live attenuated pertussis vaccine BPZE1 protects baboons against B. pertussis disease and infection.
    J Infect Dis. 2017 May 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. YAO Y, Lai R, Afkhami S, Haddadi S, et al
    A novel virus-vectored respiratory mucosal vaccine enhances anti-tuberculosis immunity in a humanized model system.
    J Infect Dis. 2017 May 20. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2017
  8. SCHNELL MJ
    Editorial to: 6-Month Safety Data of Ebola Zaire Vaccine (rVSVDeltaG-ZEBOV-GP) in a Phase III Double Blind, Placebo Controlled Randomized Study in Healthy Adults.
    J Infect Dis. 2017 Apr 18. doi: 10.1093.
    PubMed     Text format    


  9. S NELSON EA, Steele AD
    Global Impact of Rotavirus Vaccination on Childhood Hospitalizations and Mortality from Diarrhea.
    J Infect Dis. 2017 Apr 18. doi: 10.1093.
    PubMed     Text format    


  10. BURNETT E, Jonesteller CL, Tate JE, Yen C, et al
    Global Impact of Rotavirus Vaccination on Childhood Hospitalizations and Mortality from Diarrhea.
    J Infect Dis. 2017 Apr 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. LI D, Wang X, von Schaewen M, Tao W, et al
    Immunization with a subunit hepatitis C virus vaccine elicits pan-genotypic neutralizing antibodies and intra-hepatic T-cell responses in non-human primates.
    J Infect Dis. 2017 Apr 8. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  12. MOHN KG, Zhou F, Brokstad KA, Sridhar S, et al
    Live attenuated influenza vaccination boosts durable cross-reactive and protection-associated T-cells in children.
    J Infect Dis. 2017 Mar 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  13. BUCKWALTER CM, Currie EG, Tsang RS, Gray-Owen SD, et al
    Licensed meningococcal serogroup B vaccine-induced immunity against invasive disease does not reflect protection against nasal colonization in a humanized mouse model.
    J Infect Dis. 2017 Mar 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. FLANAGAN KL
    Measles Vaccination Is Effective at Under Nine Months of Age, and Provides Nonspecific Immunological Benefits.
    J Infect Dis. 2017 Mar 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. WOUDENBERG T, van der Maas NA, Knol MJ, de Melker H, et al
    Effectiveness of Early Measles, Mumps, and Rubella Vaccination Among 6-14-Month-Old Infants During an Epidemic in the Netherlands: An Observational Cohort Study.
    J Infect Dis. 2017 Mar 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. PETRIE JG, Monto AS
    Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness.
    J Infect Dis. 2017;215:841-843.
    PubMed     Text format    


  17. MARTINEZ-BAZ I, Casado I, Navascues A, Diaz-Gonzalez J, et al
    Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus.
    J Infect Dis. 2017;215:847-855.
    PubMed     Text format     Abstract available


  18. UPRETY P, Lindsey JC, Levin MJ, Rainwater-Lovett K, et al
    Inflammation and Immune Activation in Antiretroviral-Treated Human Immunodeficiency Virus Type 1-Infected African Infants and Rotavirus Vaccine Responses.
    J Infect Dis. 2017;215:928-932.
    PubMed     Text format     Abstract available


  19. LINDESMITH LC, Mallory ML, Jones TA, Richardson C, et al
    Impact of Pre-exposure History and Host Genetics on Antibody Avidity Following Norovirus Vaccination.
    J Infect Dis. 2017;215:984-991.
    PubMed     Text format     Abstract available


  20. COHEN JI
    Vaccination to Reduce Reactivation of Herpes Simplex Virus Type 2.
    J Infect Dis. 2017;215:844-846.
    PubMed     Text format    


  21. SINGH P, Verma D, Backstedt BT, Kaur S, et al
    Borrelia burgdorferi BBI39 Paralogs, Targets of Protective Immunity, Reduce Pathogen Persistence Either in Hosts or in the Vector.
    J Infect Dis. 2017;215:1000-1009.
    PubMed     Text format     Abstract available


  22. SHAY DK, Chillarige Y, Kelman J, Forshee RA, et al
    Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014.
    J Infect Dis. 2017 Mar 2. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. MONTO AS
    Moving Toward Improved Influenza Vaccines.
    J Infect Dis. 2017 Mar 2. doi: 10.1093.
    PubMed     Text format    


    February 2017
  24. KARAUZUM H, Haudenschild CC, Moore IN, Mahmoudieh M, et al
    Vaccination induces CD4 T cell-mediated mortality during Staphylococcus aureus bacteremia.
    J Infect Dis. 2017 Feb 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  25. JANES HE, Cohen KW, Frahm N, De Rosa SC, et al
    Higher T cell responses induced by DNA/rAd5 HIV-1 preventive vaccine are associated with lower HIV-1 infection risk in an efficacy trial.
    J Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed     Text format    


  26. SKOWRONSKI DM, Chambers C, De Serres G, Sabaiduc S, et al
    Serial vaccination and the antigenic distance hypothesis: effects on influenza vaccine effectiveness during A(H3N2) epidemics in Canada, 2010-11 to 2014-15.
    J Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    



  27. Flu vaccine - too much of a good thing?
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    


  28. PETRIE JG, Monto AS
    Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    


  29. MARTINEZ-BAZ I, Casado I, Navascues A, Diaz-Gonzalez J, et al
    Effect of Repeated Vaccination With the Same Vaccine Component Against Influenza A(H1N1)pdm09.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    


  30. UPRETY P, Lindsey JC, Levin MJ, Rainwater-Lovett K, et al
    Inflammation and Immune Activation in Antiretroviral-Treated HIV-1-Infected African Infants and Rotavirus Vaccine Responses.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    


  31. LINDESMITH LC, Mallory ML, Jones TA, Richardson C, et al
    Impact of Pre-Exposure History and Host Genetics on Antibody Avidity Following Norovirus Vaccination.
    J Infect Dis. 2017 Feb 1. doi: 10.1093.
    PubMed     Text format    


    January 2017
  32. BERNSTEIN DI, Wald A, Warren T, Fife K, et al
    Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection: Findings from a Randomized Trial.
    J Infect Dis. 2017 Jan 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  33. CLARK S, Lanni F, Marinova D, Rayner E, et al
    Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis.
    J Infect Dis. 2017 Jan 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  34. KAZI AM, Cortese MM, Yu Y, Lopman B, et al
    Secretor and salivary ABO blood group antigen status predict rotavirus vaccine-take in infants.
    J Infect Dis. 2017 Jan 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  35. FEROLDI E, Boaz M, Yoksan S, Chokephaibulkit K, et al
    Persistence of Wild-Type Japanese Encephalitis Virus Strains Cross-Neutralization 5 Years After JE-CV Immunization.
    J Infect Dis. 2017;215:221-227.
    PubMed     Text format     Abstract available


  36. COHEN JI
    Vaccination to Reduce Reactivation of Herpes Simplex Virus 2.
    J Infect Dis. 2017 Jan 11. pii: jix006. doi: 10.1093.
    PubMed     Text format    


  37. DO VA, Biering-Sorensen S, Fisker AB, Bale C, et al
    Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau.
    J Infect Dis. 2017 Jan 10. pii: jiw512. doi: 10.1093.
    PubMed     Text format     Abstract available


  38. RESIK S, Tejeda A, Diaz M, Okayasu H, et al
    Boosting Immune Responses Following Fractional-Dose Inactivated Poliovirus Vaccine: A Randomized, Controlled Trial.
    J Infect Dis. 2017 Jan 9. pii: jiw492. doi: 10.1093.
    PubMed     Text format     Abstract available


  39. NYOMBAYIRE J, Anzala O, Gazzard B, Karita E, et al
    First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.
    J Infect Dis. 2017;215:95-104.
    PubMed     Text format     Abstract available


  40. WEI M, Meng F, Wang S, Li J, et al
    2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study.
    J Infect Dis. 2017;215:56-63.
    PubMed     Text format     Abstract available


  41. PIERCE KK, Whitehead SS, Kirkpatrick BD, Grier PL, et al
    A Live Attenuated Chimeric West Nile Virus Vaccine, rWN/DEN4Delta30, Is Well Tolerated and Immunogenic in Flavivirus-Naive Older Adult Volunteers.
    J Infect Dis. 2017;215:52-55.
    PubMed     Text format     Abstract available


  42. HEIKKINEN T, Ojala E, Waris M
    Clinical and Socioeconomic Burden of Respiratory Syncytial Virus Infection in Children.
    J Infect Dis. 2017;215:17-23.
    PubMed     Text format     Abstract available


    December 2016
  43. HADLER JL
    Christmas-New Year influenza lull: not too late for vaccination.
    J Infect Dis. 2016 Dec 28. pii: jiw643. doi: 10.1093.
    PubMed     Text format    


  44. MANOR Y, Lewis M, Ram D, Daudi N, et al
    Evidence for Hepatitis A Virus Endemic Circulation in Israel Despite Universal Toddler Vaccination Since 1999 and Low Clinical Incidence in All Age Groups.
    J Infect Dis. 2016 Dec 24. doi: 10.1093.
    PubMed     Text format    


  45. MANOR Y, Lewis M, Ram D, Daudi N, et al
    Evidence for Hepatitis A virus endemic circulation in Israel despite universal toddlers' vaccination since 1999 and low clinical incidence in all age groups.
    J Infect Dis. 2016 Dec 23. pii: jiw611. doi: 10.1093.
    PubMed     Text format     Abstract available


  46. CHENG A, Chang SY, Sun HY, Tsai MS, et al
    Long-term durability of responses to 2 or 3 doses of hepatitis A vaccination in HIV-positive adults on antiretroviral therapy.
    J Infect Dis. 2016 Dec 23. pii: jiw605. doi: 10.1093.
    PubMed     Text format     Abstract available


  47. DONKEN R, Schurink-van 't Klooster TM, Schepp RM, van der Klis FR, et al
    Immune responses after two- versus three-doses of HPV vaccination up to 4(1/2) years post vaccination: an observational study among Dutch routinely vaccinated girls (HPV2D).
    J Infect Dis. 2016 Dec 23. pii: jiw588. doi: 10.1093.
    PubMed     Text format     Abstract available


  48. MOSLEY YC, Radder JE, Berndt A, HogenEsch H, et al
    Genome-Wide Association Mapping of the Antibody Response to Diphtheria-Tetanus-acellular Pertussis Vaccine in Mice.
    J Infect Dis. 2016 Dec 23. pii: jiw587. doi: 10.1093.
    PubMed     Text format     Abstract available


  49. HEARD I, Tondeur L, Arowas L, Demazoin M, et al
    Effectiveness of HPV vaccination on prevalence of vaccine genotypes in young sexually active women in France.
    J Infect Dis. 2016 Dec 23. pii: jiw639. doi: 10.1093.
    PubMed     Text format     Abstract available


  50. WANG X, Fan X, Bi S, Li N, et al
    Toll-like Receptor 2-and 4-Mediated Reciprocal Th17 and Antibody Responses to Group A Streptococcus Infection.
    J Infect Dis. 2016 Dec 23. pii: jiw598. doi: 10.1093.
    PubMed     Text format     Abstract available


  51. JEGASKANDA S, Co MD, Cruz J, Subbarao K, et al
    Human seasonal influenza A viruses induce H7N9-cross-reactive antibody-dependent cellular cytotoxicity (ADCC) antibodies that are directed towards the nucleoprotein.
    J Infect Dis. 2016 Dec 23. pii: jiw629. doi: 10.1093.
    PubMed     Text format     Abstract available


  52. TRIEU MC, Zhou F, Lartey S, Jul-Larsen A, et al
    Long-term maintenance of the influenza-specific cross-reactive memory CD4+ T-cell responses following repeated annual influenza vaccination.
    J Infect Dis. 2016 Dec 22. pii: jiw619. doi: 10.1093.
    PubMed     Text format     Abstract available


  53. JOHN J, Giri S, Karthikeyan AS, Lata D, et al
    The duration of intestinal immunity after an inactivated poliovirus vaccine booster dose in children immunized with oral vaccine: a randomised controlled trial.
    J Infect Dis. 2016 Dec 21. pii: jiw595. doi: 10.1093.
    PubMed     Text format     Abstract available


  54. PETRIE JG, Parkhouse K, Ohmit SE, Malosh RE, et al
    Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains.
    J Infect Dis. 2016;214:1947-1951.
    PubMed     Text format     Abstract available


  55. RAMSAUER K, Tangy F
    Chikungunya Virus Vaccines: Viral Vector-Based Approaches.
    J Infect Dis. 2016;214.
    PubMed     Text format     Abstract available


  56. DEZURE AD, Berkowitz NM, Graham BS, Ledgerwood JE, et al
    Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya Virus.
    J Infect Dis. 2016;214.
    PubMed     Text format     Abstract available


  57. ERASMUS JH, Rossi SL, Weaver SC
    Development of Vaccines for Chikungunya Fever.
    J Infect Dis. 2016;214.
    PubMed     Text format     Abstract available


  58. HENEIN S, Swanstrom J, Byers AM, Moser JM, et al
    Dissecting antibodies induced by a chimeric yellow fever-dengue, live-attenuated, tetravalent dengue vaccine (CYD-TDV) in naive and dengue exposed individuals.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  59. FEDSON DS
    Statins, Influenza Vaccination and Influenza.
    J Infect Dis. 2016.
    PubMed     Text format    


  60. COLLETT MS, Hincks JR, Benschop K, Duizer E, et al
    Antiviral activity of pocapavir in a randomized, blinded, placebo-controlled human oral poliovirus vaccine challenge model.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  61. FEDSON DS
    Statins, Influenza Vaccination and Influenza.
    J Infect Dis. 2016 Dec 7. doi: 10.1093.
    PubMed     Text format    


    November 2016
  62. BERENSON AB, Laz TH, Rahman M
    Reduction in vaccine-type human papillomavirus prevalence among adult females in the United States, 2009-2012.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  63. ABEID KA, Jani B, Cortese MM, Kamugisha C, et al
    Monovalent Rotavirus Vaccine Effectiveness and Impact on Rotavirus Hospitalizations in Zanzibar, Tanzania: Data from the First 3 Years Post-Introduction.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  64. MACHALEK DA, Chow EP, Garland SM, Wigan R, et al
    Human papillomavirus prevalence in unvaccinated heterosexual males following a national female vaccination program.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    October 2016
  65. WU Y, Chakravarty S, Li M, Wai TT, et al
    Development of a live attenuated bivalent oral vaccine against Shigella sonnei shigellosis and typhoid fever.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  66. HARRIS VC, Armah G, Fuentes S, Korpela KE, et al
    The infant gut microbiome correlates significantly with rotavirus vaccine response in rural Ghana.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  67. ITURRIZA-GOMARA M, Cunliffe NA
    Could the gut microbiome be key to understanding and improving rotavirus vaccine performance in high disease burden settings?
    J Infect Dis. 2016.
    PubMed     Text format    


  68. SCHLECHT NF, Diaz A, Shankar V, Szporn AH, et al
    RISK OF DELAYED HPV VACCINATION IN INNER-CITY ADOLESCENT WOMEN.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  69. MORI I
    Vaccination Effectively Prevents Central Nervous System Invasion by Influenza A(H5N1) Virus Through the Olfactory Pathway: A Proposed Mechanism of Neuroprotection.
    J Infect Dis. 2016.
    PubMed     Text format    


  70. LELIC A, Verschoor CP, Lau VW, Parsons R, et al
    Immunogenicity of Varicella Zoster Vaccine and Immunologic Predictors of Response in a Cohort of Elderly Nursing Home Residents.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  71. JEYANATHAN M, Damjanovic D, Yao Y, Bramson J, et al
    Induction of an immune protective T cell repertoire with diverse genetic coverage by a novel viral-vectored tuberculosis vaccine in man.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  72. XIONG X, Jiao J, Gregory AE, Wang P, et al
    Identification of Coxiella burnetii CD8+ epitopes and delivery by attenuated Listeria monocytogenes as a vaccine vector in a C57BL/6 mouse model.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available



  73. Live attenuated influenza vaccine in children induces B-cell responses in tonsils.
    J Infect Dis. 2016.
    PubMed     Text format    


    September 2016
  74. ENGLUND JA, Chu HY
    Vaccines Against Respiratory Syncytial Virus: The Time Has Come.
    J Infect Dis. 2016.
    PubMed     Text format    


  75. LANGLEY JM, Aggarwal N, Toma A, Halperin SA, et al
    A randomized, controlled, observer-blind Phase I study of the safety and immunogenicity of a Respiratory Syncytial Virus vaccine with or without alum adjuvant.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  76. HALSTEAD SB
    Dengue Vaccine Efficacy: Not a Zero Sum Game.
    J Infect Dis. 2016.
    PubMed     Text format    


  77. LIAO G, Li R, Li C, Sun M, et al
    Phase III Trial of a Sabin Strain-based Inactivated Poliovirus Vaccine.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  78. GOO L, Dowd KA, Lin TY, Mascola JR, et al
    A virus-like particle vaccine elicits broad neutralizing antibody responses in humans to all Chikungunya virus genotypes.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  79. MADAN A, Segall N, Ferguson M, Frenette L, et al
    Immunogenicity and safety of an AS03-adjuvanted H7N9 pandemic influenza vaccine in a randomized trial in healthy adults.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  80. MAYORGA O, Buhler S, Jaeger VK, Bally S, et al
    Single dose hepatitis A immunisation: 7.5 year observational pilot study in Nicaraguan children to assess protective effectiveness and humoral immune memory response.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    August 2016
  81. SINGH DK, Dwivedi VP, Ranganathan A, Bishai WR, et al
    Blockade of the Kv1.3 K+ channel enhances BCG vaccine efficacy by expanding central memory T lymphocytes.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  82. REBER AJ, Kim JH, Coleman LA, Spencer SM, et al
    Seasonal Influenza Vaccination of Children Induces Humoral and Cell-Mediated Immunity Beyond the Current Season: Cross-reactivity with Past and Future Strains.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  83. EDWARDS KM, Keitel WA
    Challenges Remain for Influenza Vaccination of Children.
    J Infect Dis. 2016.
    PubMed     Text format    


  84. KIM JH, Mishina M, Chung JR, Cole KS, et al
    Cell-mediated immunity against antigenically drifted influenza A(H3N2) viruses in children during a vaccine mismatch season.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  85. LEWNARD JA, Huppert A, Givon-Lavi N, Pettigrew MM, et al
    Density, serotype diversity, and fitness of Streptococcus pneumoniae in upper respiratory co-colonization with nontypeable Haemophilus influenzae.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  86. SIEGERS JY, van den Brand JM, Leijten LM, van de Bildt MM, et al
    Vaccination Is More Effective Than Prophylactic Oseltamivir in Preventing CNS Invasion by H5N1 Virus via the Olfactory Nerve.
    J Infect Dis. 2016;214:516-24.
    PubMed     Text format     Abstract available


  87. ADLER SP, Manganello AM, Lee R, McVoy MA, et al
    A Phase 1 Study of Four Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in CMV Seronegative Men.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  88. PINTO LA, Kemp TJ, Torres BN, Isaacs K, et al
    THE QUADRIVALENT HPV VACCINE INDUCES HPV-SPECIFIC ANTIBODIES AT THE ORAL CAVITY: RESULTS FROM THE MID-ADULT MALE VACCINE TRIAL-THE MAM TRIAL.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  89. WILDER-SMITH A, Vannice KS, Hombach J, Farrar J, et al
    Population perspectives and WHO recommendations for CYD-TDV dengue vaccine.
    J Infect Dis. 2016.
    PubMed     Text format    


  90. HALSTEAD S
    Critique of WHO Approval of a Dengue Vaccine.
    J Infect Dis. 2016.
    PubMed     Text format    


  91. WU S, Kroeker A, Wong G, He S, et al
    An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman Primates.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available



  92. A Randomized, Controlled Trial of the Impact of Alternative Dosing Schedules on the Immune Response to Human Rotavirus Vaccine in Rural Ghanaian Infants.
    J Infect Dis. 2016.
    PubMed     Text format    


    July 2016
  93. MCLEAN HQ, Chow BD, VanWormer JJ, King JP, et al
    The Effect of Statin Use on Influenza Vaccine Effectiveness.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  94. SHAFER WM
    Does the cervicovaginal microbiome facilitate transmission of Neisseria gonorrhoeae from women to men? Implications for understanding transmission of gonorrhea and advancing vaccine development.
    J Infect Dis. 2016.
    PubMed     Text format    


  95. JOHNSON RF, Kurup D, Hagen KR, Fisher C, et al
    An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  96. HOFT DF, Lottenbach K, Goll JB, Hill H, et al
    Priming Vaccination with H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  97. OLIVERA-BOTELLO G, Coudeville L, Fanouillere K, Guy B, et al
    Tetravalent dengue vaccine reduces symptomatic and asymptomatic dengue infections in healthy children and adolescents aged 2-16 years in Asia and Latin America.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    June 2016

  98. Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01.
    J Infect Dis. 2016.
    PubMed     Text format    


  99. ATMAR RL, Baehner F, Cramer JP, Song E, et al
    Rapid Responses to Two Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: A Randomized Controlled Trial.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  100. JEGASKANDA S, Luke C, Hickman HD, Sangster MY, et al
    The generation and protective ability of influenza-specific antibody-dependent cellular cytotoxicity in humans elicited by vaccination, natural infection or experimental challenge.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  101. MATTHIJSSE SM, Hontelez JA, Naber SK, Rozemeijer K, et al
    Public health benefits of routine human papillomavirus vaccination for adults in the Netherlands: a mathematical modeling study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  102. RAMPLING T, Ewer KJ, Bowyer G, Bliss CM, et al
    Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B with ChAd-MVA Vectored Vaccines Expressing ME-TRAP.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  103. BOWEN MD, Mijatovic-Rustempasic S, Esona MD, Teel EN, et al
    Rotavirus Strain Trends during the Post-Licensure Vaccine Era: United States, 2008-2013.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  104. REGULES JA, Cicatelli SB, Bennett JW, Paolino KM, et al
    Fractional third and fourth dose of RTS,S/AS01 malaria candidate vaccine: a phase 2a controlled human malaria infection and immunogenicity study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  105. MEITES E, Gorbach PM, Gratzer B, Panicker G, et al
    Monitoring for HPV Vaccine Impact among Gay, Bisexual and other Men who have Sex with Men - United States, 2012-2014.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  106. TOTA JE, Ramanakumar AV, Villa LL, Richardson H, et al
    Cervical Infection with Vaccine Human Papillomavirus (HPV) Genotypes as a Predictor of Acquisition and Clearance of Other HPV Infections.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    May 2016
  107. MOHN KG, Brokstad KA, Pathirana RD, Bredholt G, et al
    Live attenuated influenza vaccination in children induces B-cell responses in tonsils.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  108. SCRIBA TJ, Kaufmann SH, Lambert PH, Sanicas M, et al
    Vaccination against tuberculosis with whole cell mycobacterial vaccines.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  109. DE ST MAURICE A, Schaffner W, Griffin MR, Halasa N, et al
    Persistent gender disparities in invasive pneumococcal diseases in the conjugate vaccine era.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  110. LAPRISE JF, Markowitz LE, Chesson HW, Drolet M, et al
    COMPARING 2- AND 3-DOSE 9-VALENT HPV VACCINE SCHEDULES IN THE U.S.: A COST-EFFECTIVENESS ANALYSIS.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  111. PRELOG M, Gorth P, Zwazl I, Kleines M, et al
    Universal mass vaccination against Rotavirus: indirect effects on Rotavirus infections in neonates and non-vaccinated small infants not eligible for vaccination.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  112. FLANNERY B, Zimmerman RK, Gubareva LV, Garten RJ, et al
    Enhanced genetic characterization of influenza A(H3N2) viruses and vaccine effectiveness by genetic group, 2014-2015.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  113. ALI D, Banda R, Mohammed A, Adagadzu J, et al
    Strengthening Routine Immunization in Areas of Northern Nigeria at High Risk for Polio Transmission During 2012-2014.
    J Infect Dis. 2016;213 Suppl 3:S147-50.
    PubMed     Text format     Abstract available


  114. GALI E, Mkanda P, Banda R, Korir C, et al
    Revised Household-Based Microplanning in Polio Supplemental Immunization Activities in Kano State, Nigeria. 2013-2014.
    J Infect Dis. 2016;213 Suppl 3:S73-8.
    PubMed     Text format     Abstract available


  115. JOHNSON MULUH T, Hamisu AW, Craig K, Mkanda P, et al
    Contribution of Environmental Surveillance Toward Interruption of Poliovirus Transmission in Nigeria, 2012-2015.
    J Infect Dis. 2016;213 Suppl 3:S131-5.
    PubMed     Text format     Abstract available


  116. CRAIG KT, Verma H, Iliyasu Z, Mkanda P, et al
    Role of Serial Polio Seroprevalence Studies in Guiding Implementation of the Polio Eradication Initiative in Kano, Nigeria: 2011-2014.
    J Infect Dis. 2016;213 Suppl 3:S124-30.
    PubMed     Text format     Abstract available


  117. MUSA A, Mkanda P, Manneh F, Korir C, et al
    Youth Group Engagement in Noncompliant Communities During Supplemental Immunization Activities in Kaduna, Nigeria, in 2014.
    J Infect Dis. 2016;213 Suppl 3:S91-5.
    PubMed     Text format     Abstract available


    April 2016
  118. PRADOS-ROSALES R, Carreno LJ, Weinrick B, Batista-Gonzalez A, et al
    The Type of Growth Medium Affects the Presence of a Mycobacterial Capsule and Is Associated With Differences in Protective Efficacy of BCG Vaccination Against Mycobacterium tuberculosis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    March 2016
  119. MINHINNICK A, Harris S, Wilkie M, Peter J, et al
    Optimization of a Human Bacille Calmette-Guerin Challenge Model: A Tool to Evaluate Antimycobacterial Immunity.
    J Infect Dis. 2016;213:824-30.
    PubMed     Text format     Abstract available


    October 2015
  120. JONES T
    Comment on Ly and Klevens, Trends in Disease and Complications of Hepatitis A Virus Infection.
    J Infect Dis. 2015.
    PubMed     Text format    


    September 2015
  121. CLIFF JM, Cho JE, Lee JS, Ronacher K, et al
    Excessive Cytolytic Responses Predict Tuberculosis Relapse After Apparently Successful Treatment.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: